当前位置:主页 > 推荐 >

Trump Vows to Cut Drug Prices by Up to 1500% as Deadline Looms

时间:2025-08-26 11:50:42

  TMTPOST -- U.S. President Donald Trump on Monday reiterated his pledge to substantially cut drug prices as the deadline he set for pharmaceutical companies to lower prices looms.

  
 

  Credit:Freepik

  Trump said he would slash drug prices by 1,400% to 1,500%. Going to do a number on costs of drugs in US, he said during the briefing. The remarks reaffirmed his aggressive stance on pharmaceutical pricing and higher sectoral tariffs.

  Trump two weeks ago has made one of his boldest claims in his promise to reduce drug prices. “You know, we’ve cut drug prices by 1,200, 1,300 and 1,400, 1,500%,” he told reporters on August 10. He noted the reductions will start over the next two to three months. “I don’t mean 50%. I mean 14- 1,500%,” he said.

  The White House in late July said Trump had sent letters to 17 major pharmaceutical firms in the West outlining the steps they must take to lower the price of U.S. prescription drugs to “most favored nation” levels by September 29.

  Companies to receive these letters include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, EMD Serono, Roche’s subsidiary Genentech, Gilead, GSK, Johnson & Johnson, Merck, Novartis, Novo Nordisk, Pfizer, Regeneron and Sanofi. Trump in the letter warned if these companies “refuse to step up,” the U.S. government will deploy every tool in its “arsenal to protect American families from continued abusive drug pricing practices,” without specifying the possible measures.

  The Trump administration has intensified the threat of tariffs on pharmaceutical imports since it in April opened a so-called Section 232 investigation into how importing certain pharmaceutical products affects national security. The move was widely seen as a prelude to initiating tariffs on drugs.

  Trump during a Cabinet meeting on July 8 disclosed steep tariffs on the pharmaceutical sector will be announced “very soon”, while he could offer the pharmaceutical manufacturers at least a year for transition of their production to the U.S. before implementing the tariffs up to 200%.

  We’re going to give people about a year, year and a half to come in, and after that theyre going to be tariffed, Trump said in the meeting. If they have to bring the pharmaceuticals into the country, … theyre going to be tariffed at a very high rate — like 200%.

  Trump a week later said he could impose impose tariffs on pharmaceuticals by August 1 and that levies on semiconductors could come soon as well. “Probably at the end of the month, and we’re going to start off with a low tariff and give the pharmaceutical companies a year or so to build, and then we’re going to make it a very high tariff,” Trump said on July 15.

  Trump earlier this month suggested he would impose even more hefty tariffs on pharmaceutical imports. Well be putting a initially small tariff on pharmaceuticals, but in one year — one and a half years, maximum — its going to go to 150%. And then it’s going to go to 250%, because we want pharmaceuticals made in our country, Trump said in the CNBC interview on August 5.

热点推荐
1 币界午讯 比特币面临压力,机构悄然吸纳

6月19日消息: 1. 比特币面临压力,机构悄然吸纳12.5万枚BTC; 2. Binance面临关键MiCA截止日期,...

2 Coinbase宣布多项新功能,成为AI财务账户

消息,Coinbase首席执行官Brian Armstrong在活动中表示,本周对Coinbase来说是重要的一周,感谢所有...

3 RE短时触及0.47 USDT,15分钟涨幅达9.58%

消息,据OKX行情数据,RE短时触及0.47 USDT,现报0.46 USDT,15分钟内涨幅达9.58%。此前消息:Bith...

4 Arthur Hayes在短短两天内增持2900枚以太坊,

消息,BitMEX联合创始人Arthur Hayes近期通过其钱包增持了超过2900枚以太坊,价值超过500万美元。...

5 机构鲸鱼购买146,853枚HYPE,价值约1000万美

机构和鲸鱼正在购买HYPE代币。Fansara Capital钱包0x644收到146,853枚HYPE,价值约1000万美元。同时,...

6 Hyperion CEO Jung:市场低估Hyperliquid发展潜力

消息,Hyperion DeFi CEO Hyunsu Jung表示,市场可能低估了Hyperliquid从去中心化交易所向更广泛区块链...

7 麻吉大哥ETH杠杆仓位面临清算,今日亏损

消息,麻吉大哥的ETH 25倍杠杆仓位正在被清算,今日亏损32万美元,新ETH多单清算价为1685美元...

8 比特币短期清算达1.52亿美元,价格一度跌

消息,过去一小时内,比特币的清算总额达到了1.52亿美元,价格一度跌破63000美元。...

9 分析师:bubblemaps披露kins疑似内幕交易,

消息,bubblemaps披露,Solana链上代币kins存在疑似内幕交易,地址49uuet在合约公布前2分钟以127美...

10 彭博社:reserveone与M3

加密货币资产管理公司reserveone与特殊目的收购公司M3-Brigade Acquisition V Corp.的合并案已宣告失败...

成都来彰科技 蜀ICP备2025134723号-1

资讯来源互联网,如有版权问题请联系管理员删除。